0 CHECKOUT

PRODUCT FILTERS

REGION

31
31
21
18
4

COUNTRY

17
4
4
3
2

CATEGORIES

  • 34
  • 22
  • 7
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

5
11
47
66

PUBLISHED

0
2
10
66

PRODUCT TYPE

59
5
2

Search for: "DUPLICATE Singapore Pharmaceuticals and Healthcare Report Q1 2011"

Singapore Pharmaceuticals and Healthcare Report Q1 2016

Despite the small size of the Singaporean pharmaceutical market, the country's consistent drive into R&D, strong government commitment towards healthcare provision and its ageing population continue...

Published:  November 2015
Price: 

Singapore Pharmaceuticals and Healthcare Report Q3 2015

Singapore's healthcare system will continue to evolve, led by changes from the government. This is reflected in the distinct shift in policy that will see the authorities raising its contribution to...

Published:  May 2015
Price: 

Singapore Pharmaceuticals and Healthcare Report Q4 2015

Challenges to Singapore's medical tourism sector will intensify. Critically, the high cost of medical treatment relative to its regional peers will serve as a financial deterrent for foreign patients,...

Published:  August 2015
Price: 

Singapore Pharmaceuticals and Healthcare Report Q2 2015

Singapore will remain a highly attractive manufacturing base for international pharmaceutical companies due to minimal levels of operational risks and the government's support for the industry. The...

Published:  February 2015
Price: 

Singapore Pharmaceuticals and Healthcare Report Q1 2014

BMI View: The island state's consistent investment in research and development, coupled with the government's increased commitment to healthcare, will provide pharmaceutical firms opportunities - especially...

Published:  December 2013
Price: 

Singapore Pharmaceuticals and Healthcare Report Q4 2013

BMI View: Despite its small population, foreign pharmaceutical firms will continue to be interested in Singapore given the highly skilled workforce and the success the country had with its biomedical...

Published:  September 2013
Price: 

Singapore Pharmaceuticals and Healthcare Report Q3 2013

BMI View: Unlike other developed Asia Pacific countries, we note that the Singaporean government is seeking to increase its share of healthcare expenditure in light of the ageing population's rising...

Published:  May 2013
Price: 

Analyzing the Global Pharmaceutical Industry 2015

The global presence of the pharmaceutical industry is evident with the roll out of continent specific R&D programs and drugs which help companies maximize penetration of markets and garner increased...

Published:  February 2015
Price:  From

Pharmaceuticals - Global Outlook

The global outlook series on Pharmaceuticals provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings Punctuated with 46 statistically rich tables, the...

Published:  January 2012
Price:  From

Singapore Pharmaceuticals and Healthcare Report Q2 2013

BMI View: The pharmaceutical market in Singapore is small, but supported by an increasingly ageing population and the corresponding rise in the burden of diseases. The country will therefore remain...

Published:  February 2013
Price: 

Singapore Pharmaceuticals and Healthcare Report Q1 2013

BMI View Singapore will be of moderate attractiveness to investors given its small pharmaceutical market size, despite the growing demands for more pharmaceuticals and healthcare from its increasingly...

Published:  January 2013
Price: 

Singapore Pharmaceuticals and Healthcare Report Q3 2012

The Singapore Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with...

Published:  July 2012
Price: 

Singapore Pharmaceuticals and Healthcare Report Q1 2012

Business Monitor International's Singapore Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

Published:  December 2011
Price: 

Singapore Pharmaceuticals and Healthcare Report Q3 2011

The Singapore Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with...

Published:  June 2011
Price: 

Singapore Pharmaceuticals and Healthcare Report Q4 2011

Business Monitor International's (BMI) Singapore Pharmaceuticals and Healthcare Report (Q4 2011) provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government...

Published:  September 2011
Price: 

Pharmacogenomics Partnering Terms and Agreements

The Pharmacogenomics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomics partnering deals and agreements entered into by the...

Published:  November 2014
Price:  From

The Medical Device Market: Singapore

Overview Of The Medical Market In Singapore: - Singapore announced the implementation of its first set of medical device regulations in November 2007, and starting August 2010, all medical devices...

Published:  April 2015
Price:  From

Cambodia Pharmaceuticals and Healthcare Report Q4 2011

Business Monitor International's Cambodia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

Published:  October 2011
Price: 

Puerto Rico Pharmaceuticals and Healthcare Report Q1 2013

BMI View: The outcome of the upcoming elections is expected to assist in shaping the development of Puerto Rico's healthcare and pharmaceutical markets, depending on the direction of the new governor's...

Published:  January 2013
Price: 

Vietnam Pharmaceuticals and Healthcare Report Q1 2012

Business Monitor International's Vietnam Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

Published:  January 2012
Price: 
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group